Home
Home
  • Home
  • About Us About Us
    • Overview
    • Who we are
    • Why we provide advice
    • What are health technologies
    • Meetings
    • News
    • Who we work with
    • Contact Us
  • What We Do What We Do
    • Overview
    • Our Strategy
    • Work programme
    • Range of advice products
    • Quarterly Bulletin of advice
    • Early HTA Advice Service
  • Our Advice
  • Request Advice Request Advice
    • Overview
    • Form for requesting advice
  • Get Involved Get Involved
    • Overview
    • Contribute to advice
    • NHS boards
    • Patient and Public Involvement
    • Industry Involvement
    • Observe a council meeting
    • DOI Form

Advice Statement

  • Home
  • Our Advice
  • Freestyle Libre® flash glucose monitoring

Title

Output Type

Speciality

Published

Title

Freestyle Libre® flash glucose monitoring

Output Type

Advice Statement

Speciality

Endocrine, nutritional and metabolic

Published

13 July 2018

Recommendation for NHSScotland

It is recommended that flash glucose monitoring with Freestyle Libre® is available for individuals with diabetes who are actively engaged in the management of their diabetes and who intensively manage their condition with multiple daily insulin injections or insulin pump therapy.

In keeping with the Scottish Diabetes Group criteria, use should be restricted to those who:

  • Agree to attend a locally provided flash glucose monitoring education session;
  • Agree to scan glucose levels no fewer than six times per day;
  • Satisfy their clinical team that they (or carer) have the required knowledge/skills to self-manage diabetes; for example, having attended a recognised diabetes structured education programme.

Clinical review timescales should be agreed to ensure that use of the device continues to support individuals’ diabetes care management. NHS Boards should consider the continuation and discontinuation criteria contained within the Managed Clinical Network (MCN) leads interim position statement (see Annex 1).

Recipients should be encouraged to share data with their care team to facilitate clinical review and to contribute to local and national audit.

Please note a Safety Action Notice issued in September 2021, which relates to the risks of mis-identification of wearable medical devices used in the monitoring and treatment of diabetes.

NHSScotland is required to consider the Scottish Health Technologies Group (SHTG) advice.

What we were asked to look at?

We were asked to provide advice on the use of Freestyle Libre® flash glucose monitoring for patients with diabetes mellitus treated with intensive insulin therapy.

Our advice was based on a EUnetHTA rapid review of published clinical effectiveness and safety literature, but also incorporated a range of additional evidence sources including: a Healthcare Improvement Scotland economic evaluation; a patient group submission from Diabetes Scotland; and NHSScotland clinical expert input.

Why is this important?

Diabetes mellitus is a major cause of morbidity and mortality in Scotland with around 300,000 people diagnosed with the condition. Self-monitoring of blood glucose is essential for people with type 1 (T1) diabetes mellitus (DM) and is used by roughly one in 10 people with type 2 (T2) DM to manage glycaemic control and adjust insulin or other medications. Currently, finger prick self-monitoring of blood glucose (SMBG) using test strips and blood glucose meters is the most frequently used monitoring method. Freestyle Libre® is a flash glucose monitoring system comprising a handheld reader and sensor that patients wear on their upper arm, and offers an alternative to finger prick testing.  

Referred by

Scottish Diabetes Group.

Download icon
Download Advice
pdf (512 KB)
Download icon
Download Plain Language summary
pdf (302 KB)
Download icon
Download Evidence Note (including patient group submission and economic analysis)
pdf (4 MB)

Connect with Us

Please let us know if you'd like to receive regular updates on our work.


Last Updated: 31 January 2022

Scottish Health Technologies Group

© 2021, All rights reserved

  • Accessibility
  • Respecting your privacy
  • Cookies
  • Healthcare Improvement Scotland Website
  • Find us on Twitter
  • Freedom of Information

Tell us what you think


We'd love to hear your views

Was our advice useful?  Did you find what you were looking for on our website?